FDA Says Abbott Diabetes Care Inc. Issues Recall For Certain Freestyle Libre 3 Sensors Due To Risk For Inaccurate High Glucose Readings; Medtronic Removes Some McGRATH Mac Video Laryngoscopes, Updates Use Instructions For Others Due To Increased Risk For Battery Overheat & Explosion
Portfolio Pulse from Benzinga Newsdesk
Abbott Diabetes Care Inc. has issued a recall for certain Freestyle Libre 3 sensors due to the risk of inaccurate high glucose readings. Medtronic is removing some McGRATH Mac video laryngoscopes and updating use instructions for others due to an increased risk of battery overheating and explosion.
September 05, 2024 | 3:34 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Abbott Diabetes Care Inc. recalls certain Freestyle Libre 3 sensors due to potential inaccurate high glucose readings, which could impact user trust and sales.
The recall of Freestyle Libre 3 sensors due to inaccurate readings could lead to decreased consumer confidence and potential sales impact, negatively affecting Abbott's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Medtronic is addressing safety concerns by removing some McGRATH Mac video laryngoscopes and updating instructions due to battery overheating risks.
Medtronic's proactive measures to address battery overheating risks in its laryngoscopes may lead to short-term operational disruptions and costs, potentially impacting its stock price negatively.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70